Health
Researchers are developing first prognostic, therapeutic epigenetic biomarker for pancreatic cancer patients – News-Medical.Net
By 2030, pancreatic ductal adenocarcinoma (PDAC), the most lethal form of pancreatic cancer, is projected to become the second leading cause of cancer-related deaths…
By 2030, pancreatic ductal adenocarcinoma (PDAC), the most lethal form of pancreatic cancer, is projected to become the second leading cause of cancer-related deaths in the United States.
Not only are therapeutic options limited, but nearly half of all PDAC patients who have their tumors removed surgically experience disease recurrence within a year, despite receiving additional chemotherapy. For more advanced stages, only about one-third of patients have a limited response to approved chemotherapy.
…
-
General23 hours agoMaría Corina Machado awarded Nobel Peace Prize
-
Noosa News22 hours agoQueensland’s bid for net zero by 2050 unlikely under new energy plan: expert
-
General20 hours agoWestern Bulldogs extend Essendon’s losing streak with 57 point thrashing
-
Business11 hours agoThese 4 ASX mining stocks are rocketing as the rare earths boom intensifies